39
Participants
Start Date
July 31, 2014
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
LOVAZA
Subjects will be instructed to take 2 grams twice daily of oral omega-3-acid ethyl esters (Lovaza) starting with day 1 to 3 of their menstrual period. Each capsule contains 60mg of other omega-3 FA. On day 1 of their subsequent menstrual period, subjects will be instructed to discontinue.
GnRH
An intravenous bolus of exogenous GnRH (75 ng/kg dosing based on total body weight) will be administered at 6 hours.
University of Colorado Denver Anschutz Medical Campus, Aurora
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
University of Colorado, Denver
OTHER